Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/18/1997 | US5688504 Antagonists |
11/18/1997 | US5688501 Treating infectious disease caused by bacteria by administering bacteriophages obtained by serial passage through circulatory system and selected to have longer half-life |
11/18/1997 | US5688488 Composition and method for tumor imaging |
11/18/1997 | CA2176867A1 Transgenic plants |
11/18/1997 | CA1339546C Recombinant hybrid immunogloblin molecules an method of use |
11/18/1997 | CA1339545C Process for producing magnetically responsive polymer particles and applications thereof |
11/18/1997 | CA1339544C Novel glucose isomerase enzymes and their use |
11/17/1997 | CA2205074A1 Recombinant vectors |
11/13/1997 | WO1997042500A1 Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization |
11/13/1997 | WO1997042349A1 Cryptosporidium detection method |
11/13/1997 | WO1997042348A1 Process for direct sequencing during template amplification |
11/13/1997 | WO1997042345A1 Method for detecting a nucleic acid base sequence |
11/13/1997 | WO1997042343A2 Teichoic acid enzymes and assays |
11/13/1997 | WO1997042342A1 Formazan-based immunoassay |
11/13/1997 | WO1997042340A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | WO1997042338A1 Crossless retroviral vectors |
11/13/1997 | WO1997042337A1 Gene expression in monocytes and macrophages |
11/13/1997 | WO1997042336A1 A long-term and high expression, single gene retroviral vector with applications to progenitor and mature haematopoietic cells |
11/13/1997 | WO1997042335A1 Polycistronic expression plasmid for tumor-rejection |
11/13/1997 | WO1997042334A1 Vector for gene transfer into plant allowing optional deletion of marker gene |
11/13/1997 | WO1997042333A1 Methods and compositions for production of plant foodstuffs with enhanced sweet component of flavor |
11/13/1997 | WO1997042332A2 Genetically transformed cassava cells and regeneration of transgenic cassava plants |
11/13/1997 | WO1997042331A1 Process for producing transgenic inulin-generating plants |
11/13/1997 | WO1997042330A1 Chain reaction cloning |
11/13/1997 | WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/13/1997 | WO1997042328A1 Nucleic acid molecules which code the potato debranching enzyme |
11/13/1997 | WO1997042327A2 METHOD FOR INCREASING THE CONTENT OF TREHALOSE IN ORGANISMS THROUGH THE TRANSFORMATION THEREOF WITH THE cDNA OF THE TREHALOSE-6-PHOSPHATE SYNTHETASE/PHOSPHATASE OF SELAGINELLA LEPIDOPHYLLA |
11/13/1997 | WO1997042326A2 Regulating metabolism by modifying the level of trehalose-6-phosphate |
11/13/1997 | WO1997042325A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | WO1997042324A1 Use of interleukin-10 to produce a population of suppressor cells |
11/13/1997 | WO1997042323A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene |
11/13/1997 | WO1997042322A1 Glycoprotein hormone superagonists |
11/13/1997 | WO1997042321A1 Osteoclast transporter protein |
11/13/1997 | WO1997042320A1 Mutant aequorea victoria fluorescent proteins having increased cellular fluorescence |
11/13/1997 | WO1997042319A1 NOVEL Fas ANTIGEN DERIVATIVES |
11/13/1997 | WO1997042318A1 Vaccines |
11/13/1997 | WO1997042317A1 APTAMERS FOR COMPLEMENT PROTEIN C3b |
11/13/1997 | WO1997042316A1 Transgenic plants resistant to geminivirus infection |
11/13/1997 | WO1997042315A1 Transgenic plants resistant to geminivirus infection |
11/13/1997 | WO1997042313A1 Transgenic plants expressing assembled secretory antibodies |
11/13/1997 | WO1997042312A1 Transgenic mammals capable of expressing leukemia inhibitory factor |
11/13/1997 | WO1997042310A1 MUTANT cDNA ENCODING THE p85α SUBUNIT OF PHOSPHATIDYLINOSITOL 3-KINASE |
11/13/1997 | WO1997042309A1 TRANSGENIC ANIMALS DEFICIENT IN ENDOGENOUS β3-ADRENERGIC RECEPTOR AND USES THEREOF |
11/13/1997 | WO1997042307A1 Stable recombinant yeasts for fermenting xylose to ethanol |
11/13/1997 | WO1997042224A1 Neurotactin and uses therefor |
11/13/1997 | WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
11/13/1997 | WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
11/13/1997 | WO1997042210A1 Identification of essential survival genes |
11/13/1997 | WO1997041892A1 Chimeric kanamycin resistance gene |
11/13/1997 | WO1997041884A1 Method of treatment |
11/13/1997 | WO1997041834A1 Cationic virosomes as transfer system for genetic material |
11/13/1997 | WO1997041824A2 Antiangiogenic peptides derived from plasminogen |
11/13/1997 | WO1997041823A2 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE) |
11/13/1997 | WO1997041731A1 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
11/13/1997 | WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence |
11/13/1997 | WO1997033996A3 Human bikunin |
11/13/1997 | WO1997032020A3 Shc proteins |
11/13/1997 | WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
11/13/1997 | DE19620308A1 Vector for specific gene expression in vascular smooth muscle |
11/13/1997 | DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance |
11/13/1997 | DE19618125A1 Nucleinsäuremoleküle, die neue Debranching-Enzyme aus Kartoffel codieren Nucleic acid molecules encoding new debranching enzyme from potato |
11/13/1997 | CA2661090A1 Stable recombinant yeasts for fermenting xylose to ethanol |
11/13/1997 | CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions |
11/13/1997 | CA2253880A1 Chain reaction cloning |
11/13/1997 | CA2253864A1 Neurotactin and uses therefor |
11/13/1997 | CA2253834A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | CA2253832A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | CA2253803A1 Use of interleukin-10 to produce a population of suppressor cells |
11/13/1997 | CA2253600A1 Identification of essential survival genes |
11/13/1997 | CA2253561A1 Cationic virosomes as transfer system for genetic material |
11/13/1997 | CA2253494A1 Novel fas antigen derivative |
11/13/1997 | CA2253454A1 Transgenic plants expressing assembled secretory antibodies |
11/13/1997 | CA2253441A1 Glycoprotein hormone superagonists |
11/13/1997 | CA2253328A1 Polycistronic expression plasmid for tumor-rejection |
11/13/1997 | CA2253322A1 Gene expression in monocytes and macrophages |
11/13/1997 | CA2253234A1 Nucleic acid molecules coding for debranching enzymes from potato |
11/13/1997 | CA2252845A1 Chimeric kanamycin resistance gene |
11/13/1997 | CA2252795A1 Process for direct sequencing during template amplification |
11/13/1997 | CA2252470A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene |
11/13/1997 | CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/12/1997 | EP0806484A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
11/12/1997 | EP0806481A2 Method of preparation of transgenic plants resistant to viral infections and so obtained plants |
11/12/1997 | EP0806480A2 Frenolicin gene cluster |
11/12/1997 | EP0806479A1 Fermentative production of biotin |
11/12/1997 | EP0806478A2 p53as Protein and antibody therefor |
11/12/1997 | EP0806477A1 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna |
11/12/1997 | EP0805877A1 Improved method of selecting specific bacteriophages |
11/12/1997 | EP0805876A2 Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia |
11/12/1997 | EP0805875A1 Amplification of simple sequence repeats |
11/12/1997 | EP0805873A1 Methods for sensitive detection of reverse transcriptase |
11/12/1997 | EP0805871A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
11/12/1997 | EP0805870A1 Spectroscopically detectable nucleic acid ligands |
11/12/1997 | EP0805869A2 Direct gene transfer into the ruminant mammary gland |
11/12/1997 | EP0805868A1 Cells for the production of recombinant adenoviruses |
11/12/1997 | EP0805867A1 Dna integration by transposition |
11/12/1997 | EP0805866A1 Microbially derived rennin having enhanced milk clotting activity and method of producing same |
11/12/1997 | EP0805865A1 Deoxyribonucleic acid coding for glutathion-s-transferase and its use |
11/12/1997 | EP0805864A1 Papaya ringspot virus replicase gene |